Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
Advanced analytics and modeling can be used to predict downstream failures, allowing for corrective action before batches are lost.